{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:09:05Z","timestamp":1778108945141,"version":"3.51.4"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate whether prophylactic pregabalin reduces pain experienced with medication abortion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a randomized, double-blind, placebo-controlled trial of women initiating medication abortion with mifepristone and buccal misoprostol up to 70 days of gestation. Participants were randomized to 300 mg oral pregabalin or a placebo immediately before misoprostol. The primary outcome was maximum pain on an 11-point numerical rating scale, reported using real-time electronic surveys over 72 hours. Secondary outcomes included pain at each time point, ibuprofen and narcotic use, side effects, and satisfaction. We estimated that 110 women would be required to have 80% power to detect a difference in pain of 1.3 points.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Between June 2015 and October 2016, 241 women were screened and 110 were randomized (56 pregabalin, 54 placebo). Three were lost to follow-up. The primary outcome of mean maximum pain in the pregabalin group was 5.0\u00b12.6 vs 5.5\u00b12.2 in the placebo group (<jats:italic toggle=\"yes\">P<\/jats:italic>=.32). Excluding medication taken before the study capsule, ibuprofen was used by 64% (35\/55) of the pregabalin group vs 87% (45\/52) placebo (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.01). Narcotics were used by 29% (16\/55) of the pregabalin group vs 50% (26\/52) placebo (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.03). More dizziness (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001), sleepiness (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.04), and blurred vision (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.05) occurred in the pregabalin group. Satisfaction scores for the analgesic regimen were higher in the pregabalin group (very satisfied: 47% vs 22%; <jats:italic toggle=\"yes\">P<\/jats:italic>=.006).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Compared with placebo, 300 mg pregabalin coadministered with misoprostol during medication abortion did not significantly decrease maximum pain scores. Women who received pregabalin were less likely to require any ibuprofen or narcotic and were more likely to report higher satisfaction with analgesia, despite an increase in dizziness, sleepiness, and blurred vision.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT02782169.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002787","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T19:18:29Z","timestamp":1533669509000},"page":"612-618","source":"Crossref","is-referenced-by-count":22,"title":["Prophylactic Pregabalin to Decrease Pain During Medication Abortion"],"prefix":"10.1097","volume":"132","author":[{"given":"EmmaKate B.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reni","family":"Soon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Tschann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bliss","family":"Kaneshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1363\/46e0414","article-title":"Abortion incidence and service availability in the United States, 2011","volume":"46","author":"Jones","year":"2014","journal-title":"Perspect Sex Reprod Health"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31829d5a33","article-title":"Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial","volume":"122","author":"Raymond","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.fertnstert.2008.01.084","article-title":"Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study","volume":"91","author":"Livshits","year":"2009","journal-title":"Fertil Steril"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.contraception.2003.07.004","article-title":"A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation","volume":"68","author":"Hamoda","year":"2003","journal-title":"Contraception"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.contraception.2006.03.002","article-title":"Treatment of pain during medical abortion","volume":"74","author":"Penney","year":"2006","journal-title":"Contraception"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.clinthera.2014.04.020","article-title":"Perioperative pregabalin for acute pain after gynecological surgery: a meta-analysis","volume":"37","author":"Yao","year":"2015","journal-title":"Clin Ther"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/13625187.2014.950730","article-title":"Pain during medical abortion, the impact of the regimen: a neglected issue? A review","volume":"19","author":"Fiala","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/bja\/aeu293","article-title":"Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis","volume":"114","author":"Mishriky","year":"2014","journal-title":"Br J Anaesth"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpain.2013.08.011","article-title":"Determination of the effective dose of pregabalin on human experimental pain using the sequential up-down method","volume":"15","author":"Wong","year":"2014","journal-title":"J Pain"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0196-0644(96)70238-X","article-title":"Clinical significance of reported changes in pain severity","volume":"27","author":"Todd","year":"1996","journal-title":"Ann Emerg Med"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1197\/aemj.10.4.390","article-title":"Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department","volume":"10","author":"Bijur","year":"2003","journal-title":"Acad Emerg Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201809000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:54:23Z","timestamp":1689105263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201809000-00010"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002787","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}